Education & Certifications


  • BS, University of Southern California, Chemical Engineering (Emphasis in Biochemical, Biological, and Pharmaceutical Engineering, Minor in English Literature) (2024)

All Publications


  • Contractile responses of engineered human μmyometrium to prostaglandins and inflammatory cytokines. APL bioengineering Maxey, A. P., Wheeler, S. J., Travis, J. M., McCain, M. L. 2024; 8 (4): 046115

    Abstract

    Preterm labor is a prevalent public health problem and occurs when the myometrium, the smooth muscle layer of the uterus, begins contracting before the fetus reaches full term. Abnormal contractions of the myometrium also underlie painful menstrual cramps, known as dysmenorrhea. Both disorders have been associated with increased production of prostaglandins and cytokines, yet the functional impacts of inflammatory mediators on the contractility of human myometrium have not been fully established, in part due to a lack of effective model systems. To address this, we engineered human myometrial microtissues (μmyometrium) on compliant hydrogels designed for traction force microscopy. We then measured μmyometrium contractility in response to a panel of compounds with known contractile effects and inflammatory mediators. We observed that prostaglandin F2α, interleukin 6, and interleukin 8 induced contraction, while prostaglandin E1 and prostaglandin E2 induced relaxation. Our data suggest that inflammation may be a key factor modulating uterine contractility in conditions including, but not limited to, preterm labor or dysmenorrhea. More broadly, our μmyometrium model can be used to systematically identify the functional impact of many small molecules on human myometrium.

    View details for DOI 10.1063/5.0233737

    View details for PubMedID 39734362

    View details for PubMedCentralID PMC11672207